Skip to content

CorMedix CRMD Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Merck & Co. logo
Merck & Co.MRK
IAR
Integra LifeSciencesIART
Emergent Biosolutions logo
Emergent BiosolutionsEBS
Abbott logo
AbbottABT
ICU Medical logo
ICU MedicalICUI
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's preferred stock, shares authorized?
CorMedix (CRMD) reported preferred stock, shares authorized of $2M in Q1 2026.
How has CorMedix's preferred stock, shares authorized changed year-over-year?
CorMedix's preferred stock, shares authorized decreased by 0.0% year-over-year, from $2M to $2M.
What is the long-term trend for CorMedix's preferred stock, shares authorized?
Over 5 years (2020 to 2025), CorMedix's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $2M to $2M.